Skip to content
This GLP
Updated September 2026Two-month offer, then the monthly plan

OrderlyMeds review

The advertised figures belong to a new-patient starter program. The monthly plans are printed on the same page.

The verdict

OrderlyMeds charges $149 a month for compounded semaglutide and $299 for compounded tirzepatide on its monthly plans. The $74 in its headline applies to new patients only. It covers a two-month starter program at the starting dose, paid upfront. The FAQ states the standing rates in plain figures.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
Dose pricing
Flat across doses
From
From $149/mo
Dose published
Yes
Prescription
Required
Compounded
Yes — not FDA-approved
Pharmacy
Named
Availability
All 50 states

OrderlyMeds is an online GLP-1 service selling compounded semaglutide and compounded tirzepatide by weekly injection. Brand Wegovy and Zepbound plans are listed beside them at four-figure monthly prices. NAD+ and sermorelin sit in a separate longevity line. Coverage is stated as all 50 states.

  1. Who writes the prescription, and what do they see?

    A licensed provider reviews a medical form, and the pricing page describes a text-based telehealth visit. A video call is added only where the patient's state requires one. Dr. Brian Spears is named as chief medical officer, with an emergency medicine background. The individual prescriber for a given patient is not named before intake.

    Approval is stated to come within 24 hours, with delivery in five to six business days. Provider messaging, virtual consults and a coaching bundle are listed inside the price. No membership fee is charged. HSA and FSA cards are accepted.

  2. What happens when the dose goes up?

    New patients start at 0.25 mg for four weeks, per the compounded product FAQ. A patient already on a GLP-1 can start at the last prescribed dose with proof of the prescription. The FAQ states that the price does not rise with the dose. The Zepbound page gives 2.5 mg as the starting dose for tirzepatide.

  3. What the price includes

    Two tabs sit above the plans. New patients see the starter offer: $74 a month for semaglutide and $149 for tirzepatide, each billed as two months at once. Patients already on a GLP-1 see a smaller discount on the same two-month shape. Beneath both tabs, the monthly plans read $149 and $299. Six months at the monthly rate is $894 for semaglutide.

  4. What it claims, and what it cites

    Both GLP-1 lines are compounded rather than manufactured. Compounded preparations are not FDA-approved and are not reviewed by the FDA before dispensing, which the site's own footnote says. The FAQ names three pharmacies: SmartPharmaRx, Casa and PerfectRx. Each is described as a licensed 503A pharmacy.

Where it holds up, and where it does not

  • Strength: Monthly plan rates printed beside the offer
  • Strength: Price stated as the same at every dose
  • Strength: Three dispensing pharmacies named in the FAQ
  • Strength: A chief medical officer is named
  • Strength: No membership fee on either molecule
  • Limitation: The headline is a two-month new-patient offer
  • Limitation: The starter program is paid upfront
  • Limitation: Visits are text-based unless a state requires video
  • Limitation: The homepage and pricing page disagree on starter length

What the evidence says about this kind of treatment

The assessment above is about OrderlyMeds. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A buyer who reads past the starter offer to the monthly plan beneath it.
Wrong for
A buyer who expects the headline figure to recur after the second month.

How OrderlyMeds compares

SellerWho it suitsGo
TryoziBuyers who want the recurring rate and the discount ladder on one screen before startingSee Tryozi
Zera HealthA reader who budgets from the monthly rate printed beside the first-month offer.See Zera Health
CieloBuyers who want the commitment behind a headline rate spelled out in the asterisk under itSee Cielo
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: Roen RxRX BellaRx.comRxION HealthRxPepsDirectRxPros

Sponsored alternative

Bodybuilding Health+

A reader unwilling to prepay a year before seeing how the drug goes

Check Bodybuilding Health+ availability →

Frequently asked

What does semaglutide cost after the starter program?
$149 a month. The FAQ says the next month is billed at the standard monthly rate, and names $149 for semaglutide and $299 for tirzepatide.
Who qualifies for the $74 figure?
New patients who begin at the starting dose. It is sold as a two-month program paid in full upfront.
Does the price change as the dose goes up?
Not according to the FAQ, which states that all medication is the same price per dosage.
Is the pharmacy named?
Yes. SmartPharmaRx, Casa and PerfectRx are listed as the pharmacies the service works with.
Is OrderlyMeds legit?
OrderlyMeds is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
Is OrderlyMeds expensive compared with other GLP-1 telehealth sellers?
OrderlyMeds publishes a starting figure of $149/mo. Across the 368 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $449 with a median of $189, which puts OrderlyMeds below the median, toward the cheaper end. The other 20 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Dana SullivanEvidence reviewer · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from OrderlyMeds’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.